Substituted pyrrolidine carboxamide compounds
AssigneeEpizyme, Inc.
InventorsMegan Alene Cloonan Foley, Kevin Wayne KUNTZ, Lorna Helen MITCHELL, Michael John MUNCHHOF, Darren Martin HARVEY
Life of this patent
Estimating the term…
Abstract
The present disclosure provides pyrrolidine carboxamide compounds having Formula I and the pharmaceutically acceptable salts and solvates thereof, wherein A, B, X, Y, and Z are defined as set forth in the specification. The present disclosure is also directed to the use of compounds of Formula I to treat a disorder responsive to the blockade of SMYD proteins such as SMYD3 or SMYD2. Compounds of the present disclosure are especially useful for treating cancer.
Claims23
A compound having Formula I:
- or a pharmaceutically acceptable salt or hydrate thereof,
- wherein:
- A is selected from the group consisting of 1,2,3-triazolyl, 1,2,4-triazolyl, 1-imidazolyl, 1-isoquinolinyl, 1-pyrazolyl, 2-(1,2,3,4-tetrahydroquinolinyl), 2-benzo[d]imidazolyl, 2-benzo[d]thiazolyl, 2-chromenyl-4-one, 2-furanyl, 2-imidazo[1,2-b]pyridazinyl, 2-imidazolyl, 2-indolyl, 2-naphthalenyl, 2-pyrazinyl, 2-pyridyl, 2-pyrimidinyl, 2-pyrrolidinyl, 2-pyrrolyl, 2-quinolinyl, 2-quinoxalinyl, 2-thiazolo[5,4-c]pyridinyl, 2-thiazolyl, 2-thiophenyl, 3-(1,2,3,4-tetrahydroisoquinoline), 3-(1,2,4-oxadiazolyl), 3-imidazo[1,2-a]pyrimidinyl, 3-indazolyl, 3-indolyl, 3-isothiazolyl, 3-pyrazolyl, 3-pyridazinyl, 3-pyridinyl-2-one, 3-pyridyl, 3-pyrrolo[3,2-b]pyridinyl, 3-quinolinyl, 4-(2,2-difluorobenzo[d][1,3]dioxolyl), 4-cyclohexanyl-1-amine, 4-imidazolyl, 4-indolinyl-2-one, 4-indolyl, 4-isothiazolyl, 4-oxazolyl, 4-piperidinyl, 4-pyrazolyl, 4-pyridyl, 4-quinolinyl, 5-(1,3-dihydro-2H-benzo[d]imidazolyl-2-one), 5-(1,3-dihydro-2H-pyrrolo[2,3-b]pyridinyl-2-one), 5-(1,3-dihydro-2H-pyrrolo[2,3-c]pyridinyl-2-one), 5-(2,2-difluorobenzo[d][1,3]dioxolyl), 5-(2,4-dihydro-3H-1,2,4-triazolyl-3-one), 5-4H-furo[3,2-b]pyrrolyl, 5-benzo[c][1,2,5]oxadiazolyl, 5-benzo[d][1,3]dioxolyl, 5-benzo[d]oxazolyl-2(3H)-one, 5-bicyclo[2.2.1]heptyl-2-ene, 5-indolinyl-2,3-dione, 5-indolinyl-2-one, 5-indolyl, 5-isoindolinyl-1-one, 5-isoxazolyl, 5-pyrazolo[3,4-c]pyridinyl, 5-pyrazolyl, 5-pyrimidinyl, 5-thiazolyl, 6-(1,2,3,4-tetrahydronaphthalenyl), 6-(3,4-dihydroquinolinyl-2(1H)-one), 6-(3,4-dihydroquinoxalinyl-2(1H)-one), 6-(4,5-dihydropyridazinyl-3(2H)-one), 6-benzo[b][1,4]oxazinyl-3-one, 6-benzo[d]imidazolyl, 6-benzo[d]oxazolyl-2(3H)-one, 6-benzo[d]thiazolyl, 6-chromenyl-2-one, 6-imidazo[2,1-b]thiazole, 6-indazolyl, 6-indolinyl-2-one, 6-indolyl, 6-isoquinolinyl, 6-quinolinyl, 6-quinoxalinyl, 6-quinoxalinyl-2(1H)-one, 7-(3,4-dihydroquinolinyl-2(1H)-one), 7-(3,4-dihydroquinoxalin-2(1H)-one), 7-benzo[b][1,4]oxazinyl-3-one, 7-indolinyl-2-one, 7-quinolinyl, 8-benzo[b][1,4]oxazinyl-3-one, cyclopropanyl, phenyl, 4-(prop-1-en-1-yl)-imidazole, 1-butanyl-imidazole, sec-butylcyclopropane, 2-(ethyl sulfonyl)propanyl, 1-isobutylpyrrolidine, 4-pyridyl 1-oxide, and 5-benzo[c][1,2,5]oxadiazolyl 1-oxide, each of which is optionally substituted with one, two, or three substituents independently selected from the group consisting of halo, hydroxy, alkoxy, amino, alkylamino, dialkylamino, (amino)alkyl,(alkylamino)alkyl, (dialkylamino)alkyl, C1-6 alkyl, haloalkyl, hydroxyalkyl, (carboxamido)alkyl, (cycloalkyl)alkyl, optionally substituted C3-12 cycloalkyl, optionally substituted C6-14 aryl, optionally substituted 5- to 14-membered heteroaryl, optionally substituted 4- to 14-membered heterocyclo, and aralkyl;
- Y is —C(R1a)(R1b)—;
- or Y is absent;
- B is:
- X is selected from the group consisting of —S(═O)2—, —S(═O)2N(R6)—, —S(═O)2C(R7)(H)—, —C(═O)—, —C(═O)N(R6)—, —C(═O)O—, and —C(═O)C(R7)(H)—;
- or X is absent;
- Z is selected from the group consisting of hydrogen, optionally substituted C1.6 alkyl, hydroxyalkyl, (amino)alkyl, (alkylamino)alkyl, (dialkylamino)alkyl, (cycloalkylamino)alkyl, (heterocyclo)alkyl, (amino)(hydroxy)alkyl, (amino)(aryl)alkyl, (hydroxy)(aryl)alkyl, (aralkylamino)alkyl, alkoxyalkyl, optionally substituted C6-14 aryl, optionally substituted 4- to 14-membered heterocyclo, optionally substituted 5- to 14-membered heteroaryl, optionally substituted C3-12 cycloalkyl, aralkyl, and heteroaralkyl;
- R1s and R1b areindependently selected from the group consisting of hydrogen and C1-4 alkyl;
- R2a, R2b, R3a, R3b, R4a, and R4b are each independently selected from the group consisting of hydrogen, amino, alkylamino, dialkylamino, cycloalkylamino, halo, hydroxy, C1-6 alkyl, alkoxy, haloalkyl, hydroxyalkyl, (amino)alkyl, (alkylamino)alkyl, (di alkylamino)alkyl, (cycloalkylamino)alkyl, (heterocyclo)alkyl, optionally substituted C3-12 cycloalkyl, optionally substituted C6-14 aryl, optionally substituted 4- to 14-membered heterocyclo, optionally substituted 5- to 14-membered heteroaryl, alkoxyalkyl, aralkyl, alkoxycarbonyl, sulfonamido, carboxamido, —N(H)C(═O)R8a;
- and —CH2N(H)C(═O)R8b;
- or
- R2a and R2b taken together with the carbon atom to which they are attached form a carbonyl;
- and R3a, R3b, R4a, and R4b are each independently selected from the group consisting of hydrogen, hydroxy, C1-6 alkyl, alkoxy, hydroxyalkyl, C3-12 cycloalkyl, optionally substituted C6-14 aryl, alkoxyalkyl, aralkyl, —N(H)C(═O)R8a;
- and —CH2N(H)C(═O)R8b;
- or
- R3a and R3b taken together with the carbon atom to which they are attached form a carbonyl;
- and R2a, R2b, R4a, and R4b are each independently selected from the group consisting of hydrogen, hydroxy, C1-6 alkyl, alkoxy, hydroxyalkyl, C3-12 cycloalkyl, optionally substituted C6-14 aryl, alkoxyalkyl, —N(H)C(═O)R8a;
- and —CH2N(H)C(═O)R8b;
- or
- R4a and R4b taken together with the carbon atom to which they are attached form a carbonyl;
- and R2a, R2b, R3a, and R3b are each independently selected from the group consisting of hydrogen, hydroxy, C1-6 alkyl, alkoxy, hydroxyalkyl, C3-12 cycloalkyl, optionally substituted C6-14 aryl, alkoxyalkyl, —N(H)C(═O)R8a;
- and —CH2N(H)C(═O)R8b;
- or
- R2a and R2b taken together with the carbon atom to which they are attached form a C3-6 cycloalkyl or C3-6 heterocyclo;
- and R3a, R3b, R4a, and R4b are each independently selected from the group consisting of hydrogen, hydroxy, C1-6 alkyl, alkoxy, hydroxyalkyl, C3-12 cycloalkyl, optionally substituted C6-14 aryl, alkoxyalkyl, aralkyl, —N(H)C(═O)R8a;
- and —CH2N(H)C(═O)R8b;
- or
- R3a and R3b taken together with the carbon atom to which they are attached form a C3-6 cycloalkyl or C3-6 heterocyclo;
- and R2a, R2b, R4a, and R4b are each independently selected from the group consisting of hydrogen, hydroxy, C1-6 alkyl, alkoxy, hydroxyalkyl, C3-12 cycloalkyl, optionally substituted C6-14 aryl, alkoxyalkyl, —N(H)C(═O)R8a;
- and —CH2N(H)C(═O)R8b;
- or
- R4a and R4b taken together with the carbon atom to which they are attached form a C3-6 cycloalkyl or C3-6 heterocyclo;
- and R2a, R2b, R3a, and R3b are each independently selected from the group consisting of hydrogen, hydroxy, C1-6 alkyl, alkoxy, hydroxyalkyl, C3-12 cycloalkyl, optionally substituted C6-14 aryl, alkoxyalkyl, —N(H)C(═O)R8a;
- and —CH2N(H)C(═O)R8b;
- R5 is selected from the group consisting of hydrogen and C1-4 alkyl;
- R6 is selected from the group consisting of hydrogen and C1-4 alkyl;
- R7 is selected from the group consisting of hydrogen, C1-4 alkyl, amino, alkylamino, dialkylamino, (amino)alkyl, (alkylamino)alkyl, (dialkylamino)alkyl, and hydroxyalkyl;
- R8a is selected from the group consisting of C1-6 alkyl, haloalkyl, hydroxyalkyl, (amino)alkyl, (alkylamino)alkyl, (dialkylamino)alkyl, (cycloalkylamino)alkyl, (heterocyclo)alkyl, optionally substituted C6-14 aryl, optionally substituted 4- to 14-membered heterocyclo, optionally substituted 5- to 14-membered heteroaryl, optionally substituted C3-12 cycloalkyl, aralkyl, and heteroaralkyl;
- and
- R8b is selected from the group consisting of C1-6 alkyl, haloalkyl, hydroxyalkyl, (amino)alkyl, (alkylamino)alkyl, (dialkylamino)alkyl, (cycloalkylamino)alkyl, (heterocyclo)alkyl, optionally substituted C6-14 aryl, optionally substituted 4- to 14-membered heterocyclo, optionally substituted 5- to 14-membered heteroaryl, optionally substituted C3-12 cycloalkyl, aralkyl, and heteroaralkyl.
(canceled)
20-25. (canceled)
(canceled)
Dependencies are inferred from the claim text.